Relievant Medsystems Names Tyler Binney President and CEO

by Jason Rutten | May 10, 2021 | news

Relievant Medsystems, a privately held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), announced today the appointment of Tyler Binney as President and Chief Executive Officer. Mr. Binney will also join Relievant’s Board of...

Relievant Medsystems Launches Intracept.com Patient Education Website

by Jason Rutten | Jan 12, 2021 | news

Relievant Medsystems, a privately‐held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), announced today the launch of Intracept.com – a new website helping educate patients regarding the Intracept Procedure. Visitors to Intracept.com...

Relievant Medsystems Announces $70M Financing to Accelerate U.S. Commercialization of Intracept Procedure

by Jason Rutten | Oct 29, 2020 | news

Relievant Medsystems, a privately-held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), announced today the completion of a $70 million equity financing. The round was led by new investor Vensana Capital alongside Lightstone Ventures...

Relievant Announces Positive 12-Month Intracept Effectiveness Study Results From Community Based Practices

by Jason Rutten | Oct 27, 2020 | news

Relievant Medsystems, a privately-held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), today announced the North American Spine Society Journal publicationi of results from an effectiveness study showing that the significant...

Relievant Announces Publication of 5-Year Data Demonstrating Long Term Clinical Benefits of the Intracept Procedure in Chronic Low Back Pain Patients

by Jason Rutten | Jun 8, 2020 | news

Relievant Medsystems, a privately-held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), today announced European Spine Journal publication of long-term data from the Level I SMART trial showing durability of improvements in pain and...